tiprankstipranks
Agios Pharma (AGIO)
NASDAQ:AGIO
US Market
AGIO
Agios Pharma
RESEARCH TOOLSreports

Agios Pharma (AGIO) Income Statement

Compare
674 Followers

Agios Pharma Income Statement

Last quarter (Q4 2025), Agios Pharma's total revenue was $19.97M, an increase of 86.09% from the same quarter last year. In Q4, Agios Pharma's net income was $-108.04M. See Agios Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 54.03M$ 36.50M$ 26.82M$ 14.24M$ 0.00
Gross Profit
$ 47.68M$ 32.33M$ 17.32M$ 12.54M$ -18.78M
Operating Expenses
$ 519.82M$ 458.07M$ 408.81M$ 401.58M$ 359.64M
Depreciation and Amortization
$ 5.18M$ 5.65M$ 6.62M$ 8.56M$ 18.78M
EBITDA
$ -466.95M$ -420.08M$ -384.86M$ -380.48M$ -337.73M
Operating Income
$ -472.13M$ -425.74M$ -391.49M$ -389.05M$ -378.42M
Other Income/Expenses
$ 58.34M$ 1.14B$ 39.40M$ 157.25M$ 21.91M
Pretax Income
$ -413.80M$ 717.97M$ -352.09M$ -231.80M$ -356.51M
Net Income
$ -412.78M$ 673.73M$ -352.09M$ -231.80M$ 1.60B
Per Share Metrics
Basic EPS
$ -7.12$ 11.86$ -6.33$ -4.23$ -6.36
Diluted EPS
$ -7.12$ 11.64$ -6.33$ -4.23$ -6.36
Weighted Average Shares Outstanding
 57.97M 56.81M 55.65M 54.79M 60.45M
Weighted Average Shares Outstanding (Diluted)
 57.97M 57.89M 55.65M 54.79M 60.45M
Currency in USD

Agios Pharma Earnings and Revenue History